NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

COVID-19的遠程醫療的商機

Business Opportunities for Telemedicine During COVID-19 (pre-order)

出版商 MIC - Market Intelligence & Consulting Institute 商品編碼 973400
出版日期 按訂單生產 內容資訊 英文 28 Pages
商品交期: 約2個工作天內
價格
COVID-19的遠程醫療的商機 Business Opportunities for Telemedicine During COVID-19 (pre-order)
出版日期: 按訂單生產內容資訊: 英文 28 Pages
簡介

從2020年開始,世界受到COVID-19爆發很大的打擊,新確診的病例持續增加。全球的醫療系統不堪患者數重荷,人們去醫院時擔心感染風險,因此導致遠程醫療服務的需求劇增。

本報告提供遠程醫療調查分析,國際的政策,應用服務,價值鏈的商機,近幾年的遠程醫療相關的主要的問題點相關的系統性資訊。

目錄

第1章 序文

第2章 國際性政策

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
  • 亞洲
    • 中國
    • 日本

第3章 應用服務

  • 虛擬醫療諮詢
    • Teladoc Health
    • AmWell
  • 數位診斷
    • Tyto Care
    • Healthy.io
  • 數位藥局
    • Amazon Care
    • Ali Health
  • 遠距照護
    • Philips eICU
    • XR Health

第4章 遠程醫療價值鏈的商機

  • 終端設備:家庭內的生物識別設備的大成長可能性
  • 網路通訊:醫院的資料傳送的增加牽引需求
  • 應用服務:大流行後的時代的主要風險管理手法的遠程醫療

第5章 主要的問題點

  • 遠程醫療法規要求改善靈活性
  • 為了保護個人健康資料的緊急需求

第6章 MIC預測

附錄

  • 企業的清單
目錄
Product Code: NARPT20113001

Since early 2020, the world has been hit hard by the COVID-19 outbreak with new confirmed cases continuing to rise. Health systems worldwide have been overwhelmed with patients and people are worried about the risk of infection when going to hospitals. As a result, demand for telemedicine services has surged. This report discusses international policies, application services, business opportunities in the value chain, and key issues associated with telemedicine in recent years.

Table of Contents

1. Preface

2. International Polices

  • 2.1 North America
    • 2.1.1 The United States
    • 2.1.2. Canada
  • 2.2 Europe
    • 2.1.1 Germany
    • 2.1.2 UK
    • 2.1.3 France
  • 2.2 Asia
    • 2.2.1 China
    • 2.2.2 Japan

3. Application Services

  • 3.1 Virtual Medical Consultation
    • 3.1.1 Teladoc Health
    • 3.1.2 AmWell
  • 3.2 Digital Diagnostics
    • 3.2.1 Tyto Care
    • 3.2.2 Healthy.io
  • 3.3 Digital Pharmacy
    • 3.3.1 Amazon Care

3.3.2

  • Ali Health
  • 3.4 Telecare
    • 3.4.1 Philips eICU
    • 3.4.2 XR Health

4. Business Opportunities in Telemedicine Value Chain

  • 4.1 End Devices: In-home Biometric Devices Have Great Growth Potential
  • 4.2 Network Communications: Increased Data Transmission in Hospitals Boosts Inelastic Demand
  • 4.3 Application Services: Telemedicine as a Key Risk Control Technique in the Post-pandemic Era

5. Key Issues

  • 5.1 Improvement in Adaptability of Telemedicine Regulations is Required
  • 5.2 Urgent Needs for Comprehensive Protection of Personal Health Data

6. MIC Perspective

Appendix

  • List of Companies

List of Tables

  • Table 1 Number of COVID-19 Cases in G7 and BRICS Countries

List of Figures

  • Figure 1 Teladoc Health
  • Figure 2 AmWell
  • Figure 3 Tyto Care’s Digital Stethoscope
  • Figure 4 Healthy.io’s Urine Testing Device
  • Figure 5 Amazon Care
  • Figure 6 Ali Health
  • Figure 7 Philips eICU’s Telecare Center
  • Figure 8 XRHealth
  • Figure 9 Telemedicine Industry Value Chain

List of Topics

Development of telemedicine around the world, touching on international policies in North America, Europe, and Asia

Telemedicine application services in virtual medical consultation with examples of Teladoc Health and AmWell, in digital diagnostics with examples of Tyto Care and Healthy.io, in digital pharmacy with examples of Amazon Care and Ali Health, and in Telecare with examples of Philips eICU and XR Health

Business opportunities in telemedicine value chain from end devices, network communications, to application services, and includes two key issues in telemedicine

Companies covered

Accenture Canada

Ali Health

Alibaba

Allianz X

AmWell

Apple

Babylon Health

Facebook

Google

Healthy.io

LifeLabs

Oasis Medical

Orion Health

Philips

PillPack

RGAX

Roche Canada

Skype

Teladoc Health

TELUS Health

TMall Pharma

Tyto Care

Under Armour

XRHealth